Mirtazapine Classification and Mechanism of Action
Mirtazapine is a tetracyclic antidepressant classified as a Noradrenergic and Specific Serotonergic Antidepressant (NaSSA) that works by blocking presynaptic alpha-2 adrenergic receptors and postsynaptic serotonin type 2 and type 3 receptors. 1
Pharmacological Classification and Mechanism
Mirtazapine has a unique pharmacological profile that distinguishes it from other antidepressant classes:
- Primary classification: Noradrenergic and Specific Serotonergic Antidepressant (NaSSA) 2
- Chemical structure: Tetracyclic compound belonging to the piperazino-azepine group 3
- Receptor activity:
Differentiation from Other Antidepressant Classes
Mirtazapine differs from other common antidepressant classes:
- Unlike SSRIs/SNRIs, mirtazapine does not inhibit the reuptake of serotonin or norepinephrine 4
- Unlike tricyclic antidepressants (TCAs), mirtazapine has fewer anticholinergic side effects 2
- Unlike MAOIs, mirtazapine does not inhibit monoamine oxidase enzymes 3
FDA-Approved Indication
Mirtazapine is FDA-approved for the treatment of Major Depressive Disorder (MDD) in adults 3. According to the American College of Physicians guideline, it is considered a second-generation antidepressant 6.
Clinical Applications
While primarily indicated for depression, mirtazapine has several characteristics that make it useful in specific clinical scenarios:
- Faster onset of action: Evidence suggests mirtazapine may work more quickly than some SSRIs 2
- Beneficial for sleep disturbances: Its sedative properties make it useful for patients with depression and insomnia 5
- Anxiolytic effects: Shows effectiveness for anxiety symptoms accompanying depression 1
- Less sexual dysfunction: Unlike many other antidepressants, mirtazapine is not commonly associated with sexual dysfunction 5
Common Side Effects
The most frequently reported adverse effects include:
Dosing Considerations
- Starting dose: 15 mg/day administered as a single dose at bedtime 1
- Maintenance dose: Can be titrated up to 30-45 mg/day based on clinical response 4
- Pharmacokinetics: Rapid absorption, extensive hepatic metabolism, elimination half-life of approximately 22 hours allowing for once-daily dosing 4
Important Precautions
- Contraindicated with MAOIs (including 14 days after discontinuing MAOIs) 3
- Carries a black box warning regarding increased risk of suicidal thoughts and behaviors in young adults 3
- Rare but serious adverse effects include agranulocytosis and neutropenia 4
Mirtazapine's unique mechanism of action and side effect profile make it a valuable option for treating depression, particularly in patients who may benefit from its sedative properties or who experience intolerable side effects with other antidepressants.